The enhanced in vivo activity of the combination of a MEK and a PI3K inhibitor correlates with [18F]-FLT PET in human colorectal cancer xenograft tumour-bearing mice. (2013)

First Author: Haagensen EJ
Attributed to:  MRC Contribution to a CR-UK and EPSRC Cancer Imaging Initiative funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0081763

PubMed Identifier: 24339963

Publication URI: http://europepmc.org/abstract/MED/24339963

Type: Journal Article/Review

Volume: 8

Parent Publication: PloS one

Issue: 12

ISSN: 1932-6203